Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Lore Lapeire

Ghent University Hospital

Work address: Poli- en dagziekenhuis Medische oncologie C. Heymanslaan 10
9000 Gent
Email: Lore.Lapeire@UGent.be
ORCID iD: 0000-0002-5028-6305

Show Sort by

Add to list
- Journal Article
- open access
Spindle cell/sclerosing rhabdomyosarcoma with a novel YAP1-MAML2 fusion in a 1-year-old: not all strongly TRK-expressing spindle cell sarcomas in infants are infantile fibrosarcomas!

Fleur Cordier (UGent) , Eline Ameloot (UGent) , Catharina Dhooge (UGent) , Lore Lapeire (UGent) , Gwen Sys (UGent) , Jo Van Dorpe (UGent) and David Creytens (UGent)

(2021) Pathology.
Add to list
A challenging case of a poorly differentiated small cell variant of synovial sarcoma with unusual immunophenotype

Fleur Cordier (UGent) , Lore Lapeire (UGent) , Gwen Sys (UGent) , Jo Van Dorpe (UGent) and David Creytens (UGent)

(2021) PATHOLOGY.
Add to list
Diagnosis of epithelioid hemangioendothelioma 8 days postpartum : is there a link with pregnancy? : A case report and review of the literature

Nicky Somers (UGent) , David Creytens (UGent) , Simon Van Belle (UGent) , Gwen Sys (UGent) and Lore Lapeire (UGent)

(2021) ACTA CLINICA BELGICA. p.1-6
Add to list
NGS-analysis to the rescue : dual checkpoint inhibition in metastatic osteosarcoma : a case report and review of the literature

Laure Nuytemans, Gwen Sys (UGent) , David Creytens (UGent) and Lore Lapeire (UGent)

(2021) ACTA CLINICA BELGICA. 76(2). p.162-167
Add to list
- Journal Article
- A1
- open access
A phase 1 study of mTORC1/2 inhibitor BI 860585 as a single agent or with exemestane or paclitaxel in patients with advanced solid tumors

Filippo de Braud, Jean-Pascal H. Machiels, Daniela Boggiani, Sylvie Rottey (UGent) , Matteo Duca, Marie Laruelle, Stefania Salvagni, Silvia Damian, Lore Lapeire (UGent) , Marcello Tiseo, et al.

(2020) CANCERS. 12(6).
Add to list
- Journal Article
- A1
- open access
Is early integration of palliative home care in oncology treatment feasible and acceptable for advanced cancer patients and their health care providers? A phase 2 mixed-methods study

Naomi Dhollander (UGent) , Tinne Smets (UGent) , Aline De Vleminck (UGent) , Lore Lapeire (UGent) , Koen Pardon (UGent) and Luc Deliens (UGent)

(2020) BMC PALLIATIVE CARE. 19(1).
Add to list
Integration of oncology and palliative care: summary of the Lancet Oncology Commission Paper.

Naomi Dhollander (UGent) , Luc Deliens (UGent) , Stein Kaasa, JH Loge, T Lundeby, Lore Lapeire (UGent) and Kim Beernaert (UGent)

(2020) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 14(2). p.47-55
Add to list
Algorithms for molecular testing in solid tumours

A. Hébrant, M. Lammens, C. Van den Broecke, N. D’Haene, J. Van den Oord, A. Vanderstichele, A. Dendooven, P. Neven, K. Punie, G. Floris, et al.

(2019) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 13(7). p.286-295
Add to list
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act. In. Sarc) : a multicentre, phase 2-3, randomised, controlled trial

Sylvie Bonvalot, Piotr L Rutkowski, Juliette Thariat, Sebastien Carrere, Anne Ducassou, Marie-Pierre Sunyach, Peter Agoston, Angela Hong, Augustin Mervoyer, Marco Rastrelli, et al.

(2019) LANCET ONCOLOGY. 20(8). p.1148-1159
Add to list
Specifieke zorg voor jongeren met kanker : aanbevelingen uit kwalitatief onderzoek

Nathalie Belpame (UGent) , Lore Lapeire (UGent) and Sofie Verhaeghe (UGent)

(2019) HUISARTS NU. 48(4). p.164-168

1
2
3

Next →